Trading Members of the Exchange are hereby informed that effective from Wednesday, March 22, 2023, the Equity Shares of SUDARSHAN PHARMA INDUSTRIES LIMITED shall be listed and admitted to dealings on the Exchange in the list of 'MT' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.
|
Name of the company
|
SUDARSHAN PHARMA INDUSTRIES LIMITED
|
|
Registered Office:
|
301,3rd Floor, Aura Biplex Above Kalyan
Jewellers S. V. Road, Borivali (West)
Mumbai City Maharashtra 400092 India
Tel :022- 022- 42221111
Email : compliance@sudarshanpharma.com
Website : www.sudarshanpharma.com
|
|
No. of Securities
|
240,65,887 Equity Shares Of Rs.10/- each fully paid up
|
|
Distinctive Number range
|
1 To 24065887
|
|
Scrip ID on BOLT System
|
SUDARSHAN
|
|
Abbreviated Name on BOLT System
|
SUDARSHAN
|
|
Scrip Code
|
543828
|
|
ISIN No.
|
INE00TV01015
|
|
Market Lot
|
1600
|
|
Issue Price for the current Public issue
|
Rs. 73/- per share (Face Value of Rs. 10/- and premium of Rs. 63/-)
|
|
Date of Allotment in the public issue:
|
March 17, 2023
|
|
Pari Pasu
|
Yes
|
|
Financial Year
|
Mar-31
|
|
Lock in detail
|
As per Annexure I
|
|
Shareholding Pattern
|
As per Annexure II
|
a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e.1600equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.
b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Wednesday, March 22, 2023. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.
c)The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depositorys records.
d) The Market Maker to the issue as mentioned in the prospectus is given below:
|
Gretex Share Broking Private Limited
Address: Office No. 13, 1st Floor, New Bansilal Building, Raja Bahadur Mention, 9-15, Homi Modi Street, Fort, Mumbai-400023, Maharashtra, India
Tel: +91-22-40025273
E-mail: sherwoodpvtltd@yahoo.co.in
Contact person: Mr. Alok Harlalka
SEBI Registration No.: INZ000166934
|
e) The Registrar to the issue as mentioned in the prospectus is given below
|
KFIN TECHNOLOGIES LIMITED
Address: Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad 500032, Telangana, India
Tel: +91 40 6716 2222
Fax: +91 40 2343 1551
E-mail: : einward.ris@kfintech.com
Website: : www.kfintech.com
Investor Grievance E-mail: : spil.ipo@kfintech.com
Contact person: Mr. M Murali Krishna
SEBI Registration No.: INR000000221
|
f) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
|
a) At the company:
Ms. Ishita Ashok Samani Company Secretary and Compliance Officer
|
Address:
301,3rd Floor, Aura Biplex Above Kalyan
Jewellers S. V. Road, Borivali (West)
Mumbai City Maharashtra 400092 India
Tel :022- 022- 42221111
Email : compliance@sudarshanpharma.com
Website : www.sudarshanpharma.com
|
|
b) At the Exchange:
Mr. Raghavendra Bhat
Associate Manager
|
Tel.: (91) 022 2272 8915
|
Rupal Khandelwal
Assistant General Manager
Tuesday, March 21,2023 |